| |
42-day mortality
|
One-year mortality
|
|---|
| |
Model 1a
|
Model 2b
|
Model 3a
|
Model 4b
|
|---|
| |
HR
|
95 % CI
|
P value
|
HR
|
95 % CI
|
P value
|
HR
|
95 % CI
|
P value
|
HR
|
95 % CI
|
P value
|
|---|
|
All patients
| | | | | | | | | | | | |
|
Non-DM & CKD
|
Ref.
| | | | | |
Ref.
| | | | | |
|
Only DM
|
0.72
|
0.50–1.02
|
0.062
| | | |
0.80
|
0.64–1.02
|
0.066
| | | |
|
Only CKD
|
1.25
|
0.62–2.52
|
0.541
| | | |
1.07
|
0.65–1.76
|
0.801
| | | |
|
DM + CKD
|
1.99
|
1.03–3.84
|
0.042
| | | |
1.84
|
1.14–2.98
|
0.012
| | | |
|
P for DM × CKD interaction
|
0.100
| | | | |
0.028
| | | |
|
Women
| | | | | | | | | | |
|
Non-DM & CKD
| | |
Ref.
| | | | |
Ref.
| | |
|
Only DM
| | |
1.11
|
0.56–2.21
|
0.772
| | |
0.77
|
0.49–1.21
|
0.260
|
|
Only CKD
| | |
3.40
|
0.75–15.48
|
0.113
| | |
1.30
|
0.39–4.28
|
0.672
|
|
DM + CKD
| | |
4.03
|
1.40–11.59
|
0.010
| | |
2.84
|
1.31–6.14
|
0.008
|
|
Men
| | | | | | | | | | |
|
Non-DM & CKD
| | |
2.00
|
1.14–3.52
|
0.016
| | |
1.61
|
1.13–2.29
|
0.009
|
|
Only DM
| | |
1.25
|
0.67–2.32
|
0.487
| | |
1.32
|
0.90–1.92
|
0.154
|
|
Only CKD
| | |
2.02
|
0.83–4.94
|
0.123
| | |
1.64
|
0.90–2.98
|
0.108
|
|
DM + CKD
| | |
2.93
|
1.14–7.57
|
0.026
| | |
2.42
|
1.28–4.57
|
0.007
|
|
P for gender × diseases interaction
| | |
0.920
| | |
0.559
|
-
CI confidence interval, CKD chronic kidney disease, DM diabetes mellitus, HR hazard ratio, Ref reference
-
aAdjusted for sex, age, comorbidities, etiology of cirrhosis, complications of cirrhosis, low income and urbanization
-
bAdjusted for age, comorbidities, etiology of cirrhosis, complications of cirrhosis, low income and urbanization
